PROMEDIX, INC.
Automated device for rapid, quantified capillary refill time measurement to aid sepsis diagnosis and treatment decisions
- Sector
- Medtech
- Headquarters
- PORTLAND, OR
- Founded
- 2018
- Latest Form D
- $200K, Dec 2024
- Total capital
- $2M
- Federal grants
- $1.4M
- 2 awards · 2023–2025
- Rank in peer group#314 of 477
- Private capital raised
- $550K
- 4 Form D · last Dec 2024
- 22 months since last filing
- Federal contracts
- None on recordNo federal contract awards found.
- Granted patents
- 3
- 2 pending · first 2025
- Rank in peer group#99 of 477
Capital timeline
Latest events
- Federal grantNSF · Phase II · SBIR Phase II: Electronic Measurement Device of Capillary Refill Time to Improve Outcomes from Sepsis$1.1M
- Private capital raisedForm D · SEC · 4th filing$200K
- Federal grantNSF · Phase I · STTR Phase I: Electronic Measurement of Capillary Refill Time to Improve Outcomes from Sepsis$256K
- Private capital raisedForm D · SEC · 3rd filing$50K
- Private capital raisedForm D · SEC · 2nd filing$50K
- Private capital raisedForm D · SEC · 1st filing$250K
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Standing among 477 peers
Line = medianMedtech · Device
- Federal grantsBelow median
- Granted patents#99 · top 21%
Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.
Founders and team
Researcher links verified by same-company patents and grants- Steven BakerResearcherExecutive OfficerLinked by 3 patents
- Scott FilerResearcherExecutive Officer, DirectorLinked by $1.4M in grants as PI
- Andrew KiblerExecutive Officer, DirectorNamed in SEC Form D filings
- David SheridanExecutive Officer, DirectorNamed in SEC Form D filings
- Matthew HansenExecutive Officer, DirectorNamed in SEC Form D filings
- Robert JenksExecutive OfficerNamed in SEC Form D filings
What it has protected
USPTO · 3 granted of 5- PendingSystems And Methods For Measuring Capillary Refill TimeUSPTOApplication 19445349
- GrantedSystems And Methods For Measuring Capillary Refill TimeUSPTOUS 12,551,124
- GrantedSystems And Methods For Measuring Capillary Refill TimeUSPTOUS 12,465,230
Show all 5 patent records
- Systems And Methods For Measuring Capillary Refill TimeMay 21, 2026 · Application 19445349Pending
- Systems And Methods For Measuring Capillary Refill TimeFeb 17, 2026 · US 12,551,124Granted
- Systems And Methods For Measuring Capillary Refill TimeNov 11, 2025 · US 12,465,230Granted
- Systems And Methods For Measuring Capillary Refill TimeFeb 18, 2025 · US 12,226,198Granted
- Systems And Methods For Measuring Capillary Refill TimeApplication 63269245Pending
Related companies, and why
- 3Derm Systems, Inc.Similar federal contract value in Medtech · null in contracts
- PIEZO THERAPEUTICS, INC.Similar federal contract value in Medtech · null in contracts
- Neurodyne, Inc.Similar federal contract value in Medtech · null in contracts
- RELAVO, INCSimilar federal contract value in Medtech · null in contracts
- MAGSORBEO BIOMEDICAL CORPSimilar federal contract value in Medtech · null in contracts
- QATCH TECHNOLOGIES LLCSimilar federal contract value in Medtech · null in contracts
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .